Abstract：
To explore the clinical efficacy of the enhanced recovery after surgery (ERAS) program in terms of blood management for primary hip arthroplasty patients.
Ninety cases of total hip arthroplasty in our hospital from October 2020 to January 2022 were selected as the research objects, 45 cases as the control group, and 45 cases as the ERAS group. The control group was given routine care after operation, while the ERAS group was given ERAS management. The leucocytes, haemoglobin, platelets, albumin, D-dimer, C-reactive protein (CRP), total length of stay (LOS), and estimated blood loss after operation were compared between the two groups.
The results showed that the Hb, TPO, and Alb of the ERAS group before operation, one day and three days after operation were significantly higher than those of the control group (P < 0.05). The WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group (P < 0.05). The LOS in ERAS group was significantly less than that in control group (P < 0.05).
ERAS scheme can reduce the loss of blood and nutrients from surgery in patients. WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group. Humane care from ERAS programs can relieve patients\' anxiety to some extent.
ERAS management contributes to the recovery of hip function in patients undergoing THA, reduces blood loss during peri-operative period, and reduces the effect of operation on blood system.
Ninety cases of total hip arthroplasty in our hospital from October 2020 to January 2022 were selected as the research objects, 45 cases as the control group, and 45 cases as the ERAS group. The control group was given routine care after operation, while the ERAS group was given ERAS management. The leucocytes, haemoglobin, platelets, albumin, D-dimer, C-reactive protein (CRP), total length of stay (LOS), and estimated blood loss after operation were compared between the two groups.
The results showed that the Hb, TPO, and Alb of the ERAS group before operation, one day and three days after operation were significantly higher than those of the control group (P < 0.05). The WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group (P < 0.05). The LOS in ERAS group was significantly less than that in control group (P < 0.05).
ERAS scheme can reduce the loss of blood and nutrients from surgery in patients. WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group. Humane care from ERAS programs can relieve patients\' anxiety to some extent.
ERAS management contributes to the recovery of hip function in patients undergoing THA, reduces blood loss during peri-operative period, and reduces the effect of operation on blood system.
摘要：
背景：探讨强化术后康复（ERAS）计划在初次髋关节置换术患者的血液管理方面的临床疗效。
方法：选择我院2020年10月至2022年1月收治的90例全髋关节置换术患者作为研究对象。45例作为对照组,ERAS组45例。对照组术后给予常规护理。而ERAS组给予ERAS管理。白细胞，血红蛋白，血小板,白蛋白,D-二聚体,C反应蛋白(CRP),总停留时间(LOS)，比较两组患者术后估计出血量。
结果：结果显示Hb，TPO,手术前ERAS组的Alb，术后1天、3天治疗组明显高于对照组(P<0.05)。WBC,CRP,ERAS组D-二聚体水平明显低于对照组(P<0.05)。ERAS组LOS明显少于对照组(P<0.05)。
结论：ERAS方案可以减少手术患者的血液和营养损失。WBC,CRP,ERAS组D-二聚体水平明显低于对照组。ERAS项目的人道护理可以在一定程度上缓解患者的焦虑。
结论：ERAS管理有助于THA患者髋关节功能的恢复，减少围手术期的失血，减少手术对血液系统的影响。
方法：选择我院2020年10月至2022年1月收治的90例全髋关节置换术患者作为研究对象。45例作为对照组,ERAS组45例。对照组术后给予常规护理。而ERAS组给予ERAS管理。白细胞，血红蛋白，血小板,白蛋白,D-二聚体,C反应蛋白(CRP),总停留时间(LOS)，比较两组患者术后估计出血量。
结果：结果显示Hb，TPO,手术前ERAS组的Alb，术后1天、3天治疗组明显高于对照组(P<0.05)。WBC,CRP,ERAS组D-二聚体水平明显低于对照组(P<0.05)。ERAS组LOS明显少于对照组(P<0.05)。
结论：ERAS方案可以减少手术患者的血液和营养损失。WBC,CRP,ERAS组D-二聚体水平明显低于对照组。ERAS项目的人道护理可以在一定程度上缓解患者的焦虑。
结论：ERAS管理有助于THA患者髋关节功能的恢复，减少围手术期的失血，减少手术对血液系统的影响。
